1 comment

mobile_photo

Recent publications in the medical literature have cited increased mortality associated with erythromycin, azithromycin, and levofloxacin. In a search for a possible explanation for the increased number of deaths with these drugs

View Post

0 comments

mobile_photo

In the last 9 months, over 153,000 unique visitors from 174 countries have accessed the CredibleMeds website. This represents a 29 increase and 48% of visitors are from outside the U.S.

View Post

0 comments

mobile_photo

Using the list of QT prolonging drugs from the CredibleMeds website and patient information in the electronic health records, the CDSS automatically generated a risk score for QT prolongation and issued alerts to pharmacists (high risk or moderate risk).

View Post

1 comment

mobile_photo

Nelfinavir (Viracept®) and Ivabradine (Procoralan®, Coralan®, Corlentor®, Coraxan®, Ivabid®, Bradia®) have been added to the list of medicines with Conditional Risk of Torsades de Pointes (TdP).

View Post

1 comment

mobile_photo

Azithromycin has been associated with increased risk of death(1) and since June 2012 has been on the CredibleMeds list of QT-prolonging drugs that have “Known Risk of Torsades de Pointes (TdP).”

View Post

0 comments

mobile_photo

Research at AZCERT has documented the greater sensitivity of women to the effects of medicines that have effects on the heart and prolong the QT interval on the ECG, the influence of their menstrual cycle and the corresponding increase in life-threatening arrhythmias and deaths in women.

View Post

2 comments

CredibleMeds® is pleased to announce that My Medicines Forms, our new record-keeping and notification system, is now available.

View Post

0 comments

mobile_photo

CredibleMeds'® releases CredibleCDS™ - an open-source drug safety resource for use in clinical decision support systems.

View Post

0 comments

mobile_photo

Nature Reviews of Cardiology invited Dr. Raymond L. Woosley to author an article, assessing cardiovascular drug safety for clinical decision-making which appears in Volume 10 of the Cardiology Review.

View Post

0 comments

mobile_photo

The Annual Review of Pharmacology and Toxicology invited Dr. Raymond Woosley to author an article on the past, present and future of drug regulation which appears in Volume 53 of the Review.

View Post